STOCK TITAN

COSCIENS BIOPHARMA INC (CSCIF) Net Income by Year

CSCIF

COSCIENS BIOPHARMA INC reported a net loss of $10.4M in fiscal year 2025. This represents an increase of 32.3% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters COSCIENS BIOPHARMA INC has filed alongside them.

FY2025 annual
Net Income -$10.4M
YoY +32.3%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CSCIF Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income-$10.4M+32.3%-$15.3M-339.3%-$3.5M-201.1%$3.4M+141.2%-$8.4M-63.5%-$5.1M+15.3%-$6.0M-244.3%$4.2M+124.9%-$16.8M+32.7%-$25.0M+50.2%-$50.1M

CSCIF Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Net Income-$2.2M+67.6%-$1.8M+68.4%-$2.7M-89.9%-$3.7M-160.9%-$6.7M-379.8%-$5.8M-641.6%-$1.4M-65.3%-$1.4M+67.1%$2.4M-82.5%-$776K+77.3%-$860K+79.6%-$4.3M-61.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More COSCIENS BIOPHARMA INC financials

Frequently Asked Questions

What was COSCIENS BIOPHARMA INC's net income in fiscal year 2025?

COSCIENS BIOPHARMA INC reported a net loss of $10.4M in fiscal year 2025.

How fast is COSCIENS BIOPHARMA INC's net income growing?

COSCIENS BIOPHARMA INC (CSCIF) net income rose by 32.3% year over year, from -$15.3M to -$10.4M in fiscal year 2025.

How has COSCIENS BIOPHARMA INC's net income changed over the years?

Across the 11 fiscal years this page covers, COSCIENS BIOPHARMA INC (CSCIF) net income went from -$50.1M in fiscal year 2015 to -$10.4M in fiscal year 2025.

COSCIENS BIOPHARMA INC (CSCIF) reported -$2.2M in net income in Q4 2025. This represents an increase of 67.6% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what COSCIENS BIOPHARMA INC (CSCIF) reported on that line in every period on record.